Nexus AG: VERY STRONG SALES AND EARNINGS INCREASE IN THE FIRST QUARTER 2024

Donaueschingen (pta009/14.05.2024/08:45 UTC+2)

Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 15% and EBITDA by approx. 12% in the first three months of 2024. As a result, the continually positive development of sales and earnings of the last years could be continued.

Sales improved from KEUR 55,020 to KEUR 62,988 (+14.5%) in the first three months 2024. The international share of total business volume was 44.5% (3M-2023 47.6%) and amounted to KEUR 28,011 compared to KEUR 26,205 (3M-2023). Around 54% KEUR 33.942 of revenue is recurring revenue in the form of maintenance and SaaS revenue.

The consolidated surplus rose very sharply by 18.4% to KEUR 6,695 (3M-2023 KEUR 5,654). The consolidated earnings before interest, taxes, depreciation and amortisation (EBITDA) developed positively. It improved signifcantly by 11.7% to KEUR 12,953 (3M-2023 KEUR 11,602). The EBITA increased by 13.5% from KEUR 8,721 (3M-2023) to KEUR 9,898.

The earnings before interest and taxes (EBIT) rose by 8.9% to KEUR 8,373 (3M-2023 KEUR 7,688). The consolidated earnings before taxes (EBT) improved by 7.7% to KEUR 8,695 (3M-2023 8,074). Operating cashflow increased by 13.8% to KEUR 25,541 (3M-2023 KEUR 22,447). As of 31/03/2024, the company had cash resources at its disposal in the amount of KEUR 117,219 (31/12/2023: KEUR 97,434). Nexus AG had equity capital amounting to KEUR 263,852 as of 31/03/2024 (31/12/2023: KEUR 258,582) and no external liabilities. Consequently, the equity capital rate is 60.7% (31/12/2023: 62.8%).

Donaueschingen, 14th May 2024

The Managing Board

(end)

Emitter:	Nexus AG Irmastraße 1 78166 Donaueschingen Germany
Contact Person:	Hannes Wehinger
Phone:	+49 771 22960-260
E-Mail:	ir@nexus-ag.de
Website:	www.nexus-ag.de
ISIN(s):	DE0005220909 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate